Name: HSBC reduces Eli Lilly price target to US$850 from US$1,070
Uploaded: 2026-03-17T16:45:42Z
Duration: 5 min 3 s
Description: Rajesh Kumar, head of European life sciences & healthcare equity research at HSBC, joins BNN Bloomberg to discuss the bank's downgrade on Eli Lilly.

Market Call

HSBC reduces Eli Lilly price target to US$850 from US$1,070

Rajesh Kumar, head of European life sciences & healthcare equity research at HSBC, joins BNN Bloomberg to discuss the bank's downgrade on Eli Lilly.

March 17, 2026 at 12:37p.m. EDT